OTITIS EXTERNA (OE) AFFECTS 1 IN 5 DOGS IN THEIR LIFETIME1
The pain of OE and stress of at-home treatments can affect the quality of life of dogs and their owners. It can:2,3
- Affect dogs' sleep and playing behaviours
- Lead to physical and emotional disturbances in owners
- Impair dog-owner relationships
What do vets recommend and pet owner prefer?
Neptra, the only 1-dose treatment for OE with Florfenicol that is administered by vets in clinic, guaranteeing 100% compliance.
Solve everyday OE treatment with just one dose
Early, effective vet-administered treatment can be key to successful outcomes. Neptra, administered in clinic, provides a full course of treatment in just one dose!
Avoid the uncertainty and ongoing stress of repeat at-home treatment with Neptra
- The first ONE-dose treatment for OE
- Vet-administered to guarantee 100% compliance
- Flexible recheck to suit you, the patient and the owner
The only 1-dose treatment with florfenicol
When indicated, florfenical is a 1st-line antibiotic; see the Protect Me guidelines*6
Neptra offers a combination of 3 active ingredients that work together against the most common pathogens associated with OE.
ANTI-INFLAMMATORY
Mometasone furoate
- A potent, fast-acting steroid
- Starts relieving pain and inflammation in just 30 minutes‡5
ANTIBIOTIC
Florfenicol
When indicated, Florfenicol is a first line antibiotic; see the PROTECT ME guidelines*6
ANTI-FUNGAL
Terbinafine hydrochloride
- Provides potent anti-fungal activity
- Highly effective against M. pachydermatis, a common fungal pathogen associated with otitis externa
Neptra targets the most common bacteria in OE, so you can:
- Reserve broader spectrum antibiotics for complex cases7
- Avoid "leftover" antibiotics lingering in owners' homes
- Keep OE treatment in safe hands
Give dogs relief from the pain and discomfort of everyday OE 5,8
With its unique combination of active ingredients, Neptra's 1-dose solution:
- Effectively treats up to 94% of routine canine OE cases**8
- Is licensed for the treatment of the most common pathogens of OE cases (Staphylococcus pseudintermedius and Malassezia pachydermatis)
- Provides lasting efficacy after one application, with continuous clinical improvement until day 289
For petsNeptra treats the pain and inflammation of OE effectively, offering relief without multiple treatments.
For ownersNeptra can relieve stress and help protect the bond they have with their pets.
For youNeptra can give you confidence that the job has been done, effectively, there and then.
Provide much needed relief, by keeping OE treatment in safe hands with Neptra
Product Assembly
Download Resources
Get the full details, videos and resources by logging into MyElanco.
Not registered yet? Don't miss out, see the benefits of MyElanco.
Neptra Vet Detailer
Information for vets about applying Neptra, responsible antibiotic use and Neptra's efficacy with just one dose.
CPD Resources
Otitis Externa: Top Tips from the Experts - PART 1
In Part 1 of the webinar Otitis Externa – Top Tips from the Experts, Dr Luisa Cornegliani discusses otitis externa, a diagnostic approach to the disease and the importance of cytological examination.
*for otitis associated with cocci; topical antibiotics may not always be required.6
‡Tmax reached in 30 minutes. Neptra Summary of Product Characteristics 2023.
**otitis associated with Staphylococcus pseudintermedius.8
- Paterson S et al. Companion Animal 2021 26:Sup3, S1-S16
- Jamet J-F, et al. Prospective study of the effect of otitis externa before and after treatment on 20 owners’ assessment of their and their dog’s quality of life. Vet Dermatol 2016;27:45 (abstract).
- Noli C, et al. Impact of a terbinafine-florfenicol-betamethasone acetate otic gel on the quality of life of dogs with acute otitis externa and their owners. Vet Dermatol 2017;28:386–e90.
- Dog Owner Compliance Evaluation, June 2019, n=2000 dog owners from FR/IT/ES/DE/NL/BE/UK/AU.
- Neptra Summary of Product Characteristics 2023.
- BSAVA/SAMSoc ‘Antibiotic Use in Our Practice’ poster 2023’ bsavalibrary.com/protectmeposter.
- Barnard et al 2017. In Practice 39: 386-398.
- Lynch SA, Helbig KJ. The Complex Diseases of Staphylococcus pseudintermedius in Canines: Where to Next? Vet Sci 2021;8:11.
- Fitzgerald R. Proceedings of the British Veterinary Dermatology Spring Meeting 2021 73.
- Elanco Neptra Marketing Research May 2022.
